Harmonizome 3.0

From DrugBank Drug Targets

interacting proteins for the INS 316 drug from the curated DrugBank Drug Targets dataset.

From CMAP Signatures of Differentially Expressed Genes for Small Molecules

genes differentially expressed following the flufenamic acid-316 small molecule perturbation from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.

From HuBMAP ASCT+B Annotations

biomarker genes for the Brain_CT2_LRL 316 cell type from the HuBMAP ASCT+B dataset.

From HuBMAP ASCT+B Augmented with RNA-seq Coexpression

biomarker genes for the Brain_CT2_LRL 316 cell type from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset.

From DGIdb Drug Targets 2026

interacting proteins for the CP-316,311 drug from theDGIdb Drug Targets 2026 dataset.

From Rummagene Transcription Factor Associations 2026

target genes of the PMC11042960-aging-16-205711-s002.pdf-316-IKZF2_IKZF2 transcription factor from the Rummagene Transcription Factor Associations 2026 dataset.

From GeneRIF Biological Term Annotations

genes co-occuring with the biological term ins in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.

From Guide to Pharmacology Chemical Ligands of Receptors

receptors of the Ins(3 4 5 6)P₄ ligand (chemical) from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset.

From Guide to Pharmacology Protein Ligands of Receptors

receptors of the INS ligand (protein) from the curated Guide to Pharmacology Protein Ligands of Receptors dataset.

From HumanCyc Pathways

proteins participating in the 1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3) pathway from the HumanCyc Pathways dataset.

From Pathway Commons Protein-Protein Interactions

interacting proteins for INS from the Pathway Commons Protein-Protein Interactions dataset.

From Reactome Pathways 2014

proteins participating in the Synthesis of IP2, IP, and Ins in the cytosol pathway from the Reactome Pathways dataset.

From TISSUES Text-mining Tissue Protein Expression Evidence Scores

proteins co-occuring with the tissue ins-1 cell in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.

From TISSUES Text-mining Tissue Protein Expression Evidence Scores

proteins co-occuring with the tissue ins-1 823/13 cell in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.

From TISSUES Text-mining Tissue Protein Expression Evidence Scores

proteins co-occuring with the tissue ins-1e cell in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.

From LINCS L1000 CMAP CRISPR Knockout Consensus Signatures

genes differentially expressed following the INS gene perturbation from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.

From Reactome Pathways 2024

proteins participating in the Synthesis of IP2, IP, and Ins in the cytosol pathway from the Reactome Pathways 2024 dataset.

From TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025

proteins co-occuring with the tissue INS-1 cell in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.

From TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025

proteins co-occuring with the tissue INS-1E cell in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.

From TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025

proteins co-occuring with the tissue INS-1 823/13 cell in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.

From DGIdb Drug Targets 2026

interacting proteins for the INS(3,4,5,6)P4 drug from theDGIdb Drug Targets 2026 dataset.